Vikki Flemington
Impact in
-
- Protein Degradation and Inhibitors
- Melanoma and MAPK Pathways
- RNA Interference and Gene Delivery
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 3
- Melanoma and MAPK Pathways 2
- PI3K/AKT/mTOR signaling in cancer 2
- CRISPR and Genetic Engineering 1
- Surgery 2
- Co-authors
- Richard A. Ward (2 shared papers)Paul D. Smith (2 shared papers)Nicolas Floc’h (1 shared paper)Stephen E. Fawell (1 shared paper)Darren McKerrecher (1 shared paper)Matthew King (1 shared paper)Ian G. Ganley (1 shared paper)Karen Roberts (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry (1 paper)Chemical Science (1 paper)SLAS DISCOVERY (1 paper)Oncogene (1 paper)Chemical Reviews (1 paper)
- Partner nations
- United KingdomUnited StatesBrazil
In The Last Decade
Vikki Flemington
9 papers receiving 574 citations
Vikki Flemington's Hit Papers
Peers
Comparison fields: 5 of 75
- Physiology 23
- Molecular Biology 338
- Cancer Research 63
- Oncology 107
- Biomaterials 50
Countries citing papers authored by Vikki Flemington
This map shows the geographic impact of Vikki Flemington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikki Flemington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikki Flemington more than expected).
Fields of papers citing papers by Vikki Flemington
This network shows the impact of papers produced by Vikki Flemington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikki Flemington. The network helps show where Vikki Flemington may publish in the future.
Co-authors
The 25 scholars most cited alongside Vikki Flemington, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Challenges and Opportunities in Cancer Drug Resistance Hit paper breakdown → | 2020 | 350 |
| 2 | 2015 | 79 | |
| 3 | 2019 | 53 | |
| 4 | 2016 | 51 | |
| 5 | 2013 | 30 | |
| 6 | 2021 | 9 | |
| 7 | 2020 | 4 | |
| 8 | 2024 | 2 | |
| 9 | 2013 | 1 |
About Vikki Flemington
Vikki Flemington is a scholar working on Molecular Biology, Surgery, Cell Biology, Organic Chemistry and Genetics, having authored 9 papers that have together received 579 indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (3 papers), Melanoma and MAPK Pathways (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Cancer Mechanisms and Therapy (1 paper), CRISPR and Genetic Engineering (1 paper), HER2/EGFR in Cancer Research (1 paper), Metabolism and Genetic Disorders (1 paper) and Endoplasmic Reticulum Stress and Disease (1 paper). The work is most often cited by research in Physiology (23 citations), Molecular Biology (338 citations), Cancer Research (63 citations), Oncology (107 citations) and Biomaterials (50 citations). Vikki Flemington has collaborated with scholars based in United Kingdom, United States and Brazil. Frequent co-authors include Richard A. Ward, Paul D. Smith, Nicolas Floc’h, Stephen E. Fawell, Darren McKerrecher, Matthew King, Ian G. Ganley, Karen Roberts, Ryan Greenwood and Kay T. Yeung. Their work appears in journals such as Bioorganic & Medicinal Chemistry, Chemical Science, SLAS DISCOVERY, Oncogene and Chemical Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.